Innovation New Jersey
  • Home
  • Our Coalition
    • Contact Us
  • News
  • Resources
    • State Supports
    • Federal Supports
    • Higher Ed Supports
  • Join Us

Innovation News

Everything Innovation. Everything New Jersey.
Follow us and stay connected.

EDA: CCIT Graduate Orthobond Corporation Turns to State Support in Quest to Improve Patients’ Health, Lifestyle

4/1/2016

0 Comments

 
​Trenton, NJ ― New Jersey is known the world over as a leader in innovation, and its biotechnology startups like Orthobond Corporation strive daily to improve quality of life for patients throughout the world.
 
Orthobond, a graduate of the New Jersey Economic Development Authority’s (EDA) Commercialization Center for Innovative Technologies (CCIT) in North Brunswick, has developed a surface modification technology with antimicrobial characteristics that can be applied to virtually any material.
 
The company’s proprietary “linker” technology enables Orthobond to work in a variety of areas of medicine by altering surfaces to improve adhesion and lubricity.  The biotechnology’s primary goal is to produce safe and effective surfaces for medical devices that will help to fight infections stemming from surgeries, ultimately leading to improvements in patients’ health and lifestyle. 
​Collaborations with a variety of companies have allowed Orthobond, which began as a startup at Princeton University, to improve its technology as it continues to seek additional partners and explore new applications.  The company is in discussions with several potential partners and anticipates having exciting news later in 2016.
 
“A venture that began in a Princeton University laboratory has grown into an operation on the verge of making a global impact,” EDA CEO Melissa Orsen said. “The EDA is pleased to have extended support to Orthobond through a variety of programs as it has grown.” 
 
During its time at CCIT, Orthobond grew from two to four laboratories and expanded from a staff of three to 11. In 2013, the biotechnology company entered into a lease with the EDA for just over 7,050 square feet of generic wet lab space at the Biotechnology Development Center II (BDC).
 
Known as a “tweener,” the BDC is ideal for companies that have outgrown an incubator but are not ready to move into a much larger facility.
 
Like CCIT, the BDC is part of the Technology Centre of New Jersey campus. Located in the heart of the State’s “Bioscience Cluster” between Rutgers and Princeton Universities, the Technology Centre of New Jersey sits on 75-acre campus and consists of approximately 325,000 square feet of lab, production and office space; as well as approximately 560,000 square feet of “build-to-suit sites.
 
Orthobond is also one of more than 500 New Jersey companies to take advantage of the State’s Technology Business Tax Certificate Transfer (NOL) Program. Administered by the EDA and the New Jersey Department of Treasury’s Division of Taxation, this competitive program enables eligible technology and biotechnology companies to sell New Jersey tax losses and/or research and development tax credits to raise cash to finance their growth and operations.
 
@NJEDATech spoke with Orthobond’s Chief Executive Officer Marc Burel about his company’s experience in New Jersey and its plan for the future:
 
Why did Orthobond choose to locate in New Jersey? 
 
Because of our association with Princeton University, our roots are in New Jersey. As an added bonus, we were able to secure exceptional talent from the surrounding pharmaceutical industry and the State’s renowned universities.    
 
What resources did Orthobond find most useful during its time at CCIT?
 
We appreciated the atmosphere the incubator offered; the conference rooms allowed us to meet potential partners in a professional environment and we were able to interact and collaborate with other CCIT tenants.
 
We also shared a multitude of resources, including scientific equipment and office supplies, and received an abundance of support from the EDA staff. They were always looking for ways to assist in making us successful.
 
What’s the company’s biggest success to date?
 
Orthobond is proud of the partnerships it has developed. These high-level collaborations include working with a partner that plans to submit its product to the U.S. Food and Drug Administration (FDA) for approval this year.  
 
What’s on the horizon for Orthobond?
 
We look forward to supporting one of our partners through the FDA submission process, continuing to expand our partner base, and the commercialization of our technology.
 
The EDA offers a multitude of resources to help technology grow and thrive. To learn about these resources, visit http://www.njeda.com/tls and follow @NJEDATech on Twitter and LinkedIn.
 
0 Comments



Leave a Reply.

    Do not miss a single innovative moment and sign up for our newsletter!
    Weekly updates


    Categories

    All
    3D Printing
    Academia
    Acquisitions
    Aerospace
    Agriculture
    AIDS
    Algae
    Alumni
    Animals
    Architecture
    Astrophysics
    Autism
    Awards
    Big Data
    Bioethics
    Biofuel
    Biomedical
    BioNJ
    Bioterrorism
    Bit Coins
    Brain Health
    Business
    Camden
    Cancer
    CCollege
    Cellular
    Centenary
    Chemistry
    ChooseNJ
    Climate Change
    Clinical Trials
    Cloud Tech
    Collaboration
    Computing
    Congress
    Coriell
    Council On Innovation
    Crowdfunding
    Cybersecurity
    DARPA
    Defense
    Degree
    Dementia
    Dental Health
    DOC
    DOD
    DOE
    Drew
    Drones
    Drug Creation
    Einstein's Alley
    Electricity
    Energy
    Engineering
    Entrepreneurship
    Environmental
    FAA
    Fairleigh Dickinson
    FDA
    Federal Budget
    Federal Government
    Federal Labs
    Federal Program
    Finance
    Food Science
    Fort Monmouth
    Fuel Cells
    Funding
    Genome
    Geography
    Geology
    Global Competition
    Google
    Governor Christie
    Grant
    Hackensack
    HackensackUMC
    Healthcare
    Health Care
    HHS
    HINJ
    Hospitals
    Immigration
    Incubator
    Infrastructure
    International
    Internet
    Investor
    IoT
    IP
    IT
    Jobs
    Johnson & Johnson
    K-12
    Kean
    Kessler
    Legislation
    Logistics
    Manufacturing
    Medical Devices
    Med School
    Mental Health
    Mentor
    Microorganisms
    Molecular Biology
    Montclair
    NAS
    Neuroscience
    Newark
    New Jersey
    NIFA
    NIH
    NIST
    NJBDA
    NJBIA
    NJ Chemistry Council
    NJCU
    NJDOLWD
    NJEDA
    NJEDge
    NJHF
    NJII
    NJIT
    NJMEP
    NJPAC
    NJPRO
    NJTC
    Nonprofit
    NSF
    OpEd
    Open Data
    OSHE
    OSTP
    Parasite
    Patents
    Paterson
    Patients
    Perth Amboy
    Pharma
    POTUS
    PPPL
    Princeton
    Prosthetics
    Ranking
    Rare Disease
    R&D Council
    Report
    Resiliency
    Rider
    Robotics
    Rowan
    Rutgers
    SBA
    Seton Hall
    Siemens
    Smart Car
    Smart Cities
    Software
    Solar
    Space
    SSTI
    Startup
    State Government
    STEM
    Stevens
    Stockton
    Subatomic
    Supports
    Sustainability
    Taxes
    TCNJ
    Teachers
    Telecom
    Therapy
    Thermodynamics
    Transportation
    Undergraduate
    USEDA
    Verizon
    Video Game
    Virtual Reality
    Water
    WHO
    William Paterson
    Women In STEM
    Workforce Development

Home   Coalition   News   Resources   Events   Join Us
Picture
Innovation New Jersey Coalition
10 West Lafayette Street
Trenton, NJ 08608-2002
609-858-9507